Tiverton Asset Management’s Core Laboratories CLB Stock Holding History

Tiverton Asset Management’s Portfolio CLB Stock Details CLB Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q2	–	Sell	-5,012	Closed	-$542K	–	428
2018 Q1	$542K	Sell	5,012 -15,038	-75%	-$1.66M	0.04%	209
2017 Q4	$2.2M	Sell	20,050 -14,436	-42%	-$1.44M	0.14%	135
2017 Q3	$3.4M	Sell	34,486 -4,311	-11%	-$418K	0.19%	125
2017 Q2	$3.93M	Sell	38,797 -12,833	-25%	-$1.38M	0.21%	122
2017 Q1	$5.96M	Hold	51,630	–	–	0.31%	105
2016 Q4	$6.2M	Hold	51,630	–	–	0.37%	98
2016 Q3	$5.8M	Buy	+51,630	New	+$5.95M	0.47%	80
2016 Q2	–	Sell	-91,387	Closed	-$10.3M	–	155
2016 Q1	$10.3M	Sell	91,387 -8,613	-9%	-$895K	0.35%	90
2015 Q4	$10.9M	Hold	100,000	–	–	0.35%	89
2015 Q3	$9.98M	Buy	100,000 +25,000	+33%	+$2.72M	0.22%	99
2015 Q2	$8.55M	Buy	+75,000	New	+$9.09M	0.17%	117

Other funds holding CLB

WCM Investment Management Laguna Beach, California $55.2B AUM 57.07% 1-Year Est. Return

ClearBridge Investments New York $121B AUM 27.52% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Kayne Anderson Rudnick Investment Management Los Angeles, California $32.2B AUM 10.98% 1-Year Est. Return

EARNEST Partners Atlanta, Georgia $27.7B AUM 52.44% 1-Year Est. Return

Massachusetts Financial Services Boston, Massachusetts $315B AUM 27.84% 1-Year Est. Return

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

EIP

Epoch Investment Partners New York $17.6B AUM 34.17% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Tiverton Asset Management's CLB Position: Q2 2018 in Review

Tiverton Asset Management sold out of Core Laboratories (CLB) in Q2 2018, closing a stake of 5,012 shares — an estimated $542K sold.

Tiverton Asset Management first reported a position in CLB in Q2 2015 and held it in 11 quarters. The position peaked at $10.9M in Q4 2015. 374 funds tracked by Wall St. Rank hold CLB as of Q2 2018.

Tiverton Asset Management reported no remaining Core Laboratories position as of Q2 2018 after selling out during the quarter.
Tiverton Asset Management sold 5,012 Core Laboratories shares in Q2 2018, an estimated $542K.
Tiverton Asset Management first reported a position in Core Laboratories in Q2 2015 and held it in 11 quarters.
Tiverton Asset Management's Core Laboratories position peaked at $10.9M in Q4 2015.
374 funds tracked by Wall St. Rank held Core Laboratories as of Q2 2018.

Based on Tiverton Asset Management's 13F filing for Q2 2018, filed 10 Aug 2018.